To launch updated guidance, WHO, the UN special programme HRP* and the International Agency for Research on Cancer (IARC) will host a webinar to detail new recommendations on screening and treatment for cervical pre-cancer, best practices and implications for national programmes.
The guidelines include recommendations for the general population as well as for women living with HIV/AIDS.
Background
In 2020, all WHO Member States endorsed the Global Strategy towards the Elimination of Cervical Cancer at the World Health Assembly - the first elimination strategy for a cancer in WHO’s history.
The strategy outlines three measurable global targets to prevent and treat cervical cancer:
- By 2030, 90% of girls should be fully vaccinated with HPV vaccine by 15 years of age;
- 70% of women should be screened using a high-performance test by age 35, and again by age 45;
- 90% of those identified with cervical disease should receive appropriate treatment.
These updated recommendations provide important guidance to countries to support them in achieving the 70-90 targets related to screening and treatment of cervical pre-cancer.
Increased awareness, and dissemination, use and scale-up of these recommendations will improve equity, increase access to services, and improve the health of women, and play a significant role in reducing the burden of cervical cancer in counties around the world.
Products to be launched include:
- WHO guidelines for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition
When
Two time slots are available to accommodate global audiences:
- Session 1 : 9h00 to 10h30 CET (Geneva time)
- Session 2 : 14h30 to 16h00 CET (Geneva time)
How
No registration required. Link to join: https://who.zoom.us/j/96323941459
Password: LAUNCH.123
Contact
Myriam Cortes, cortesm@who.int
* The UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction